Skip to content
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
You are currently viewing Harvard takes a new trip into the world of psychedelic drugs

Harvard takes a new trip into the world of psychedelic drugs

  • Post author:Olly PP
  • Post published:February 23, 2022
  • Post category:Industry News
Tags: Industry Media

Read more articles

Previous PostAfter Its Vilification In The 1960s, There Is Now A Renaissance In Psychedelic Drugs To Help Treat Depression And Mental Health Issues
Next PostPersisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees

You Might Also Like

Read more about the article 6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in ‘magic’ mushrooms after authorities eased rules

6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in ‘magic’ mushrooms after authorities eased rules

April 7, 2022
Read more about the article Psychedelics: A neuroscientist’s guide to how they change your brain

Psychedelics: A neuroscientist’s guide to how they change your brain

August 1, 2022
Read more about the article New study looks at ‘magic’ mushrooms as treatment for depression, without the psychedelic high

New study looks at ‘magic’ mushrooms as treatment for depression, without the psychedelic high

July 27, 2022

Recent Posts

  • Albert Labs Announces Private Placement
  • Letter of Intent (LOI) for First-In-Human studies with iNGENū CRO
  • Albert Labs Provides Corporate Update
  • Psychedelic Therapy isn’t Fringe Anymore
  • Can Psychedelics Cure?

Recent Comments

    Innovative mental health medicines for patients with unmet needs

    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy
    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy

    © 2022 Albert Labs. All Rights Reserved

    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    Twitter Linkedin Youtube Envelope
    CSE:ABRT
    FSE: VB50
    CSE:ABRT
    FSE: VB50

    About Albert Labs

    We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

    If you would like support or more information around making an investment, please contact investing@albertlabs.com

    Twitter Linkedin Youtube Envelope

    Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope

    By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok